Clinical Trials Logo

Clinical Trial Summary

The current practice of pre-VCUG antibiotic prophylaxis is highly variable. A recent unpublished survey of Society of Fetal Urologists (SFU) completed by this study team found that 87% of respondents reported having patients who develop fUTI following VCUG, with 30% of respondents prophylaxing for fUTI in patients undergoing VCUG. The current lack of best practice guidelines regarding antibiotic prophylaxis prior to VCUG due to low quality of current literature, and a growing concern around risks of unnecessary antibiotic exposure suggests the need for an RCT. The results of this pilot trial will inform the ability to conduct a definitive RCT on this important subject. The results of the definitive trial would have important clinical and economic implications.


Clinical Trial Description

What are the Study Objectives? The primary objective of this pilot trial is to determine the feasibility of conducting a definitive trial investigating whether pre-VCUG antibiotic prophylaxis, when compared to placebo, decreases the risk of fUTI in infants undergoing VCUG for genitourinary abnormalities. The pilot trial will address specific feasibility outcomes including process, resources, management and scientific domains. The pilot will lay the groundwork for the eventual full trial. Funding for the full trial will be sought after preliminary data is collected from the pilot study. The primary objective for the definitive trial is to determine whether single-dose, preprocedural antibiotic prophylaxis compared to placebo lowers the risk of fUTI in children < 3 years of age who are undergoing VCUG for the following indications: high-grade (SFU Classification III, IV/UTD 2,3) HN, ureteral dilatation, or bladder abnormalities found during renal ultrasound. The secondary outcomes of the definitive trial will include assessment of adverse event outcomes related to antibiotic prophylaxis administration, including antibiotic resistant UTI pathogens, episodes of antibiotic associated diarrhea, and C. difficile. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05438082
Study type Interventional
Source McMaster University
Contact Sarah Khan, MD
Phone 9055212100
Email khan259@mcmaster.ca
Status Not yet recruiting
Phase Phase 4
Start date October 2023
Completion date December 2024

See also
  Status Clinical Trial Phase
Terminated NCT03028129 - Prevention of Tuberculosis in Prisons Phase 4
Completed NCT05612542 - Pediatric Cardiac Surgery Comparing Short 24-hour Antibiotic Prophylaxis to Extended Antibiotic Prophylaxis
Completed NCT03765645 - Comparison of 9 Doses vs 3 Doses of Post Operative Antibiotics in Live Liver Donors N/A
Completed NCT03306290 - Serum Concentration of CEFOxitin Used for Antibiotic Prophylaxis in Obese Patients Undergoing BARiatric Surgery N/A
Recruiting NCT03283878 - Antibiotic Prophylaxis in Patients Undergoing Elective TKA- Multi-center Trial Phase 4
Recruiting NCT05654896 - Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma Phase 3
Recruiting NCT05609240 - Colo-Pro_2: Bolus-continuous Infusion Cefuroxime Prophylaxis for the Prevention of Infections After Colorectal Surgery Phase 2
Withdrawn NCT04280237 - Pharmacological Study of Cefazolin Antibioprophylaxis in Liver Transplantation
Completed NCT02479503 - Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey
Completed NCT00818766 - Efficacy of Post-operative Antibiotic Prophylaxis for Thoracic Surgery Requiring Tube Thoracostomy. N/A
Recruiting NCT05755789 - Intermittent Cefoxitin Administration Versus Loading Bolus Followed by Continuous Infusion for the Prevention of Surgical Site Infection in Colorectal Surgery Phase 3
Withdrawn NCT01880112 - Serum and Tissue Cefazolin Concentrations in Normal Weight Patients Undergoing Cesarean Delivery. Phase 4
Withdrawn NCT03982810 - The Role of Guideline-adherent Perioperative Antibiotic Administration and the Risk of Surgical Site Infections After Non-cardiac Surgery.
Recruiting NCT03269604 - Effectiveness of Three Times of Starting Antibiotic Prophylaxis in Patients With Asymptomatic Bacteriuria. N/A
Terminated NCT03386227 - Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT N/A
Completed NCT02809729 - Antibiotic Prophylaxis in Oncological Surgery of Breast N/A
Completed NCT03412305 - The Effect of Antibiotic Prophylaxis Associated With Dental Implant Surgery Phase 4
Completed NCT03790254 - D Mannose for Prevention and Treatment of RUTIs
Recruiting NCT05519072 - Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA Phase 4
Not yet recruiting NCT05813184 - Prenatal Antibiotics and Breast Milk / Neonatal IgA